82
Participants
Start Date
December 27, 2024
Primary Completion Date
August 31, 2027
Study Completion Date
February 28, 2028
ISM6331
"Dosage form: Capsule for oral administration.~Frequency of administration: Once daily overall of treatment."
RECRUITING
University of Pennsylvania - Abramson Cancer Center, Philadelphia
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago
RECRUITING
NEXT Oncology - Austin, Austin
RECRUITING
Sarah Cannon Research Institute at HealthONE, Denver
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
InSilico Medicine Hong Kong Limited
INDUSTRY